Psychopharmacologic Treatment of Panic, Generalized Anxiety Disorder, and Social Phobia-Reference-Cited by-同舟云学术

Psychopharmacologic Treatment of Panic, Generalized Anxiety Disorder, and Social Phobia

Published:1993-12 Issue:4 Volume:16 Page:719-735
ISSN:0193-953X
Container-title:Psychiatric Clinics of North America
language:en
Short-container-title:Psychiatric Clinics of North America

Author:

Roy-Byrne Peter,Wingerson Dane,Cowley Deborah,Dager Stephen

Publisher

Elsevier BV

Subject

Psychiatry and Mental health

Reference88 articles.

1. Ballenger JC: Use of carbamazepine in alprazolam discontinuation. Presented at the 144th Annual Meeting of the American Psychiatric Association, New Orleans, LA, May 11–16, 1991

2. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial, I: Efficacy in short-term treatment;Ballenger;Arch Gen Psychiatry,1988

3. Generalized anxiety and generalized anxiety disorder: Description and reconceptualization;Barlow;Am J Psychiatry,1986

4. Fluoxetine for the treatment of social phobia;Black;J Clin Psychopharmacol,1992

5. DSM-IIΙ generalized anxiety disorder: An empirical investigation of more stringent criteria;Breslau;Psychiatry Res,1988

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The assessment and treatment of panic disorder in general practice;South African Family Practice;2012-11

2. Venlafaxine extended release (XR) in the treatment of panic disorder;Therapeutics and Clinical Risk Management;2007-02

3. Panic disorder in the elderly may be associated with depression or other comorbid conditions and typically requires long-term treatment;Drugs & Therapy Perspectives;2004-09

4. Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study;Depression and Anxiety;2004

5. Diagnosis and Management of Panic Disorder in Older Patients;Drugs & Aging;2003